• There are no suggestions because the search field is empty.
RA Strategy for MD and IVD - Regulatory Affairs - QbD Group (2)

RA Strategy for Medical Devices and IVDs

Bringing your product to market requires more than just meeting legal requirements—it demands a strategic approach that minimizes risks, accelerates time to market, and ensures ongoing compliance. With constantly evolving regulations and an increasing focus on product safety and efficacy, it’s crucial to have a regulatory strategy tailored to your specific needs

Our expertise in MD and IVD regulatory affairs allows us to guide you through each step of the process, from development to market access, offering solutions that align with your product's unique characteristics and intended use.

 

What is regulatory strategy?

A regulatory strategy is an essential framework that delineates the necessary steps and actions to effectively address the regulatory requirements for introducing a product, such as a Medical Device (MD) or In Vitro Diagnostic (IVD), to the market.

 

A well-developed regulatory strategy guarantees that a product adheres to all legal, safety, and performance standards, while also minimizing delays, costs, and risks. It encompasses a range of activities, from pre-market processes like clinical trials and product testing, to post-market surveillance and compliance, thereby providing a structured guide for achieving successful market entry.

 

Discover how we can support you.

 

How we can support you

Our comprehensive regulatory strategy services are designed to support you at every stage of your product’s life cycle, addressing the specific challenges that arise within the MD and IVD sectors.

Tailored regulatory strategy

We’ll work closely with you to assist in developing a comprehensive regulatory strategy tailored to the specific IVD or MD product. This involves assessing regulatory requirements, identifying potential challenges, and formulating a plan for successful product registration and approval.

Regulatory liaison

Acting as intermediaries between your company and regulatory authorities, we’ll facilitate communication, respond to queries, and ensure a smooth interaction throughout the regulatory review process.

Risk management

We’ll guide you through identifying and assessing potential risks, helping to develop risk management plans and supporting documentation that meet all regulatory requirements.

Labeling and advertising compliance

Ensure that product labeling and advertising materials comply with regulatory requirements. This includes reviewing and advising on the content to ensure accuracy, clarity, and compliance

Post-Market Surveillance

Assist in developing and implementing post-market surveillance plans to monitor product performance and compliance after market release.

Incident reporting and corrective actions

In the event of serious incidents, we’ll help manage the reporting process and advise on corrective actions to address any compliance issues that arise.

Transition support

Whether you are transitioning from IVDD to IVDR or from MDD to MDR, we will provide expert guidance to ensure a smooth and efficient process, minimizing disruptions and keeping your product on track.

Training solutions

We offer tailored training programs designed to empower your team with the regulatory knowledge they need to stay ahead of compliance challenges.

Support for startups

For emerging companies, we provide dedicated support throughout the product development phase, helping you establish a solid regulatory foundation from the very beginning.

Why partner with QbD Group?

EXCEPTIONAL RA SERVICES THAT MEET YOUR NEEDS​ 

Tailored expertise and full life cycle support: With over 10 years of experience, QbD Group offers unparalleled expertise in regulatory affairs. Our team of highly qualified consultants provides support throughout the entire product life cycle—from pre-market development to post-market surveillance—ensuring your product meets regulatory standards at every stage.

Global reach, local expertise: With offices across Europe and South America, QbD Group operates on a global scale, enabling us to manage regulatory challenges in diverse regions and efficiently execute projects worldwide.

Customer-centric approach: At QbD Group, we prioritize your needs. We offer transparent communication, clear objectives, and continuous evaluation to ensure your satisfaction and success. Whether you're an established company or a startup, we work collaboratively with you to achieve your goals.

RA Strategy for MD and IVD - Regulatory Affairs - QbD Group

Related content

preview_image
Whitepaper

Regulatory Affairs for Pharma and Biotech

In this flyer, you will learn more about the regulatory services QbD Group provides for the pharmaceutical and biotechnology industries.
preview_image
Whitepaper

Clinical Evaluation for Medical Devices under MDR

This whitepaper will guide you through crucial regulatory documents pertaining to the clinical evaluation process of your medical device. Download now!
preview_image
Whitepaper

IVDR extension: what does this mean for you?

In this whitepaper, you will learn the impact of the IVDR transition extension and receive tips and strategies to navigate these regulatory changes.
preview_image
Webinar

Drug-Device Combination Products and Article 117

Explore the regulatory complexities of Drug-Device Combination Products. Learn about Article 117 requirements, Notified Body Opinions, and more.

 

contact-mail

Get in touch

Ready to streamline your regulatory journey?

Contact us today to discuss how our tailored strategy can help you achieve seamless market access and compliance.

RA_Get in touch